mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0088 |
0.8 |
mRNA |
Rapamycin |
GDSC1000 |
pan-cancer |
AAC |
0.013 |
0.8 |
mRNA |
MI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.0096 |
0.8 |
mRNA |
FR-180204 |
GDSC1000 |
pan-cancer |
AAC |
-0.0084 |
0.8 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0076 |
0.8 |
mRNA |
Mitomycin-C |
GDSC1000 |
pan-cancer |
AAC |
-0.0085 |
0.8 |
mRNA |
681640 |
GDSC1000 |
pan-cancer |
AAC |
-0.0089 |
0.8 |
mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
L-685458 |
CTRPv2 |
pan-cancer |
AAC |
0.0086 |
0.8 |
mRNA |
silmitasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.0089 |
0.8 |